Karl and Erum interview Eduardo Abeliuk, CEO and co-founder of Teselagen. Teselagen is a software-based automation platform for the biotech industry. Eduardo shares his background
Eduardo Abeliuk is a Chilean physicist and electrical engineer who built an enterprise solution for R&D projects with colleagues from Stanford.
Dr. Eduardo Abeliuk discusses TeselaGen Biotech’s mission, biotech trends, digitalization, and future wishes for advancements in AI and its impact on daily life.
Welcome to another episode of The Action and Ambition Podcast! Joining us today is Dr. Eduardo Abeliuk, a U.S.-based entrepreneur and technologist with over twenty years of experience driving technology development and innovation at various high-tech companies in the US.
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
TeselaGen founder, president and COO Mike Fero, PhD, had the opportunity to speak with Mark Sylvester, host of Making Waves Conversations on TedX Santa Barbara.
Our CEO and founder of Teselagen, Eduardo Abeliuk, presented a webinar on Teselagen’s Design and Build Platform, and introduced us to its applications.
With advancements in artificial intelligence and cloud computing technologies, there are a growing number of solutions in Computer-Aided Biology. But what exactly are the problems? We speak with Dr Mike Fero, the former CEO and current COO of TeselaGen – one of the first big AI companies in the Computer-Aided Biology, on the problems facing scientists and how CAB companies should be articulating that problem.
Taking synthetic biology to the high throughput era “Synthetic Biology continues to move forward at speed, enabled by the iterative cycle of ‘Design-Build-Test-Learn’ (DBTL) for